FDA Panel Backs MGI's Aquavan - With Proviso
This article was originally published in The Pink Sheet Daily
Executive Summary
Sedative not for use for those untrained in general anesthesia, advisors recommend.
You may also be interested in...
FDA Rejects Eisai’s Aquavan Injection
Advisory panel had voted in favor of propofol prodrug, with conditions; timeline for sedative’s resubmission is uncertain.
FDA Rejects Eisai’s Aquavan Injection
Advisory panel had voted in favor of propofol prodrug, with conditions; timeline for sedative’s resubmission is uncertain.
Eisai Strengthens Oncology Position With $3.9 Billion MGI Pharma Acquisition
MGI sale comes less than two weeks after the biopharma said it was exploring "strategic alternatives."